Clinical Trial Update: The Effect of Pioglitazone on Neointima Volume and Inflammatory Markers [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing the effect of pioglitazone on neointima volume and inflammatory markers in patients with diabetes mellitus and coronary arter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Stenosis
• Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Korea University Anam Hospital | Conditions: Diabetes Mellitus, Coronary Artery Stenosis | Phase 4 | Status: COMPLETED